Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

3126

1

NATURAL RESOURCE PARTNERS LP Natural Resource Partners Reports 30% Revenue Decline, Net Income Drop in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3127

1

SENSIENT TECHNOLOGIES CORP Sensient Technologies Reports 8% Revenue Growth, Improved Operating Income in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3128

1

Consolidated Communications Holdings, Inc. Consolidated Communications Reports Revenue Decline, Reduced Losses in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3129

1

Aris Water Solutions, Inc. Aris Water Solutions Reports 13% Revenue Growth, 34% Net Income Increase in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3130

1

Kearny Financial Corp. Kearny Financial Corp. Reports Decline in Net Income, Net Interest Income Amid Increased Deposits and Cash Reserves

Via official filing (AI summary) | 20 days ago | 0 comments

3131

1

Enpro Inc. Enpro Inc. Reports Strong Q3 2024 Performance with Net Income Surging 138%

Via official filing (AI summary) | 20 days ago | 0 comments

3132

1

iWallet Corp iWallet Corp. Reports Net Loss, Reduced Operating Loss, and Increased Cash Position in Latest Quarter

Via official filing (AI summary) | 20 days ago | 0 comments

3133

1

GOODYEAR TIRE & RUBBER CO /OH/ Goodyear Tire & Rubber Company Reports Mixed Q3 2024 Results, Net Loss Narrows

Via official filing (AI summary) | 20 days ago | 0 comments

3134

1

DuPont de Nemours, Inc. DuPont Reports 4% Revenue Growth in Q3 2024, Net Income Up 41%

Via official filing (AI summary) | 20 days ago | 0 comments

3135

1

NOVANTA INC Novanta Reports 10.3% Revenue Growth, $1.42 Billion in Total Assets as of September 27, 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3136

1

Bank7 Corp. Bank7 Corp. Reports Significant Financial Improvements in Q3 2024, Net Income Up 50.5%

Via official filing (AI summary) | 20 days ago | 0 comments

3137

1

CRISPR Therapeutics AG CRISPR Therapeutics Reports Mixed Q3 Results, Revenue Growth and Expense Reductions Offset by Net Loss

Via official filing (AI summary) | 20 days ago | 0 comments

3138

1

uniQure N.V. uniQure Reports Revenue Growth, Improved Profitability, and Strategic Developments in Q3 and Nine Months 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3139

1

Century Therapeutics, Inc. Century Therapeutics Reports Q3 2024 Financial Results, Collaboration Revenue Growth Amid Ongoing Losses

Via official filing (AI summary) | 20 days ago | 0 comments

3140

1

Beam Therapeutics Inc. Beam Therapeutics Reports Decline in Revenue and Net Loss, Despite Strategic Developments

Via official filing (AI summary) | 20 days ago | 0 comments

3141

1

TERADATA CORP /DE/ Teradata Reports Mixed Q3 2024 Results with Slight Revenue Growth and Improved Profitability

Via official filing (AI summary) | 20 days ago | 0 comments

3142

1

ICHOR HOLDINGS, LTD. Ichor Holdings Reports 7.3% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3143

1

Vishay Precision Group, Inc. Vishay Precision Group Reports Decline in Financial Performance for Q3 2024 and Nine Months Ended September 28, 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3144

1

Inozyme Pharma, Inc. Inozyme Pharma Reports Financial Results, Advances Clinical Trials for Lead Product Candidate INZ-701

Via official filing (AI summary) | 20 days ago | 0 comments

3145

1

Nuvectis Pharma, Inc. Nuvectis Pharma Reports Improved Operating and Net Losses, Raises $8.1M Through ATM Offering

Via official filing (AI summary) | 20 days ago | 0 comments

3146

1

Amalgamated Financial Corp. Amalgamated Financial Corp. Reports Strong Q3 and Nine-Month Results, Driven by Asset Growth and Increased Interest Income

Via official filing (AI summary) | 20 days ago | 0 comments

3147

1

AquaBounty Technologies, Inc. AquaBounty Technologies Reports Significant Financial Decline, Net Loss Increases 240% in Latest Quarter

Via official filing (AI summary) | 20 days ago | 0 comments

3148

1

Portillo's Inc. Portillo's Reports 6.9% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3149

1

Global Business Travel Group, Inc. Global Business Travel Group Reports 5% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 20 days ago | 0 comments

3150

1

Karyopharm Therapeutics Inc. Karyopharm Therapeutics Reports Mixed Q3 2024 Results, Ongoing Challenges in Profitability

Via official filing (AI summary) | 20 days ago | 0 comments